Drug and Medical Device Lawsuits

Many transvaginal mesh implants were unnecessary, caused complications

A Consumer Reports article on the hazards of certain medical devices recommends that patients protect themselves by considering what alternatives are available.

In the case of transvaginal mesh implants, for example, patients should ask their doctors what will happen if they don’t get the devices. According to the report, many women who received transvaginal mesh for pelvic organ prolapse – where the pelvic organs move out of alignment because of weakened muscles – never needed the surgery.

The report quotes Daniel S. ...

continue reading...

Consumer Reports: Medical device approval process deeply flawed

A new issue of Consumer Reports includes an investigation into the process by which the federal Food and Drug Administration reviews medical implants for approval.

The report concludes that most medical devices aren’t tested before being implanted in patients’ bodies. The situation amounts to what’s essentially a large-scale medical experiment carried out on unwitting test subjects, made up of members of the public.

“For most implants and other high-risk devices brought to market, manufacturers do nothing more than file some paperwork and ...

continue reading...

Patients rights groups oppose federal legislation that limits compensation for injury

Many patients’ rights groups are criticizing a measure that passed in the U.S. House of Representatives last week, which would restrict patients’ ability to pursue claims against negligent medical providers, including drug and medical device manufacturers.

According to Public Citizen, H.R. 5, the Protecting Access to Healthcare (PATH) Act, imposes an arbitrary $250,000 cap on non-economic damages, which would have a disproportionate impact on those with little or no earned income, such as children, full-time mothers and seniors.

Conservative groups such as ...

continue reading...

Report questions timing of hip implant recall

A major Australian newspaper is questioning why the country’s regulatory agency for drugs and medical devices allowed DePuy’s all-metal hip implants to be sold there for years after data showed they had a high early failure rate.

The report in the Sydney Morning Herald mentions documents the New York Times obtained through the Freedom of Information Act, which indicated that DePuy executives sold the devices in the United States and abroad despite knowing that they were potentially dangerous for patients who ...

continue reading...

New York Times: Company knowingly sold defective implants

Johnson & Johnson executives decided to phase out a replacement hip joint and sell its remaining inventory to be surgically implanted in patients just weeks after the company got a letter from the Food and Drug Administration about serious safety concerns with the devices.

The Times cites documents it attained under the Freedom of Information Act.

A report in the New York Times says that after receiving the letter, company executives waited a year to take the DePuy hip implants off the ...

continue reading...

Mother who lost job from implant wants reforms

A mother of three who had to quit her truck-driving job because of debilitating pain from a faulty vaginal mesh implant spoke up on Thursday, calling for federal lawmakers to close the loophole that allowed the implant to go on the market in the first place.

“It’s a question of loss,” said Colorado resident Jay Nevarez. “I lost my job and my health, and am in the process of losing my home.”

According to a report in The Boston Globe, Nevarez joined ...

continue reading...
Page 133 of 139 «...110120130131132133134135...»